, Volume 46, Issue 7–8, pp 430–436 | Cite as

Separation of human orosomucoid major gene products using immobilized copper affinity chromatography and identification of the metal-interactive residues

  • H. Sun
  • J. L. Dage
  • H. B. Halsall


The major gene products of human orosomucoid, GP1 and GP2, were purified using immobilized copper affinity chromatography [Cu(II)-IMAC], with 3 mM imidazole as eluent. Both gene products bound to the Cu(II)-IMAC column in the presence of 1 M NaCl, but at different pHs. GP1 was not retained after treatment with diethylpyrocarbonate (DEPC). This modification was characterized using difference absorbance spectrophotometry and mass spectrometry. The latter provided unambiguous assignment of some of the modified residues. No correlation was observed between the modification of histidine/tyrosine and protein retention. Furthermore, removal of the carbethoxy groups of modified histidine and tyrosine by hydroxylamine treatment did not improve the retention.

Therefore neither histidine nor tyrosine could be the critical residues in metal recognition. Results from mass spectrometric analysis of retained and unretained fractions of DEPC modified GP 1 indicated that the lysine residues 130/135 and 152 were modified significantly in both fractions, but to a relatively less extent in the retained one. We suggest that the retnetion of GP1 involves several residues including lysines, and that a critical number of these is necessary for retention.

Key Words

Column liquid chromatography Metal affinity Orosomucoids Glycoprotein Mass spectrometry detection 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    E. J. Sarcione, Arch. Biochem. Biophys100, 516 (1963).CrossRefGoogle Scholar
  2. [2]
    G. A. Ricca, J. M. Taylor, J. Biol. Chem256, 1199 (1981).Google Scholar
  3. [3]
    T. Ikenaka, H. Bammerlin, H. Kaufmann, K. Schmid, J. Biol. Chem241, 5560 (1965).Google Scholar
  4. [4]
    L. Dente, G. Ciliberto, R. Cortese, Nucleic Acids Res13, 3941 (1985).Google Scholar
  5. [5]
    K. Schmid, H. Kaufmann, S. Isemura, F. Bauer, J. Emura, T. Motoyama, M. Ishiguro, S. Nanno, Biochemistry12, 2711 (1973).CrossRefGoogle Scholar
  6. [6]
    K. Schmid, in P. Baumann, C. B. Eap, W. E. Müller, J.-P. Tillement (Editors), Alpha1-Acid Glycoprotein, Alan R. Liss, Inc., New York, p. 7 (1989).Google Scholar
  7. [7]
    K. Schmid, in The Plasma Proteins: Structure, Function and Genetic Control, Academic, London, Vol. 1, p. 183 (1975).Google Scholar
  8. [8]
    H. Iwase, Int. J. Biochem.20, 479 (1988).CrossRefGoogle Scholar
  9. [9]
    M. Treuheit, C. Costello, H. B. Halsall, Biochem. J.283, 105 (1992).Google Scholar
  10. [10]
    G. Walz, A. Aruffo, W. Kolanus, M. Bevilacenua, B. Seed, Science250, 1132 (1990).Google Scholar
  11. [11]
    L. Rabehi, F. Ferriere, L. Saffar, L. Gattegno, Glycoconjugate J.12, 7 (1995).CrossRefGoogle Scholar
  12. [12]
    M. Qin, S. Øie, J. Pharm. Pharmacol.46, 896 (1994).Google Scholar
  13. [13]
    Y. C. Liao, J. M. Taylor, J. L. Vinnice, G. A. Clawson, E. A. Sinchler, Mol. Cell. Biol.5, 3634 (1985).Google Scholar
  14. [14]
    L. Dente, M. G. Pizza, A. Metspalu, R. Cortese, EMBO J.6, 2289 (1987).Google Scholar
  15. [15]
    C. B. Eap, P. Baumann, in P. Baumann, C. B. Eap, W. E. Müller, J.-P. Tillement (Editors), Alpha1-Acid Glycoprotein, Alan R. Liss, Inc., New York, p. 111 (1989).Google Scholar
  16. [16]
    C. B. Eap, C. Cuendet, P. Baumann, Hum. Genet.80, 183 (1988).CrossRefGoogle Scholar
  17. [17]
    L. Tomei, C. B. Eap, P. Baumann, L. Dente, Hum. Genet.84, 89 (1989).CrossRefGoogle Scholar
  18. [18]
    F. Hervé, E. Gomas, J.-C. Duché, J. P. Tillement, Brit. J. Clin. Pharmacol.36, 241 (1993).Google Scholar
  19. [19]
    C. B. Eap, C. Cuendet, P. Baumann, Naunyn-Schmiedeberg's Arch. Pharmacol.337, 220 (1988).CrossRefGoogle Scholar
  20. [20]
    C. B. Eap, C. Cuendet, P. Baumann, J. Pharm. Pharmacol.40, 767 (1988).Google Scholar
  21. [21]
    F. Hervé, J.-C. Duché, P. d'Athis, C. Marché, J. Barré, J.-P. Tillement, Pharmacogentecs6, 403 (1996).Google Scholar
  22. [22]
    R. Belaiba, P. Riat, S. Urien, F. Bree, E. Albengres, J. Barné, J.-P. Tillement, in P. Baumann, C. B. Eap, W. E. Müller, J.-P. Tillement (Editors), Alpha1-Acid Glycoprotein, Alan R. Liss, Inc., New York, p. 287 (1989).Google Scholar
  23. [23]
    J. W. Paxton, Methods. Find. Exp. Clin. Pharmacol.5, 635 (1983).Google Scholar
  24. [24]
    J. Hermansson, Trends Anal. Chem.8, 251 (1989).CrossRefGoogle Scholar
  25. [25]
    E. Hervé, J.-C. Duché, N. Sportes, J.-P. Tillement, J. Chromatogr.539, 405 (1991).CrossRefGoogle Scholar
  26. [26]
    F. H. Arnold, Biotechnology9, 151 (1991).CrossRefGoogle Scholar
  27. [27]
    E. M. Miles, Methods in Enzymol.47, 431 (1977).CrossRefGoogle Scholar
  28. [28]
    H. B. Halsall, T. Kirley, M. Friedman, Prep. Biochem12, 111 (1982).Google Scholar
  29. [29]
    H. B. Halsall, T. Kirley, Arch. Biochem. Biophys.216, 392 (1982).CrossRefGoogle Scholar
  30. [30]
    L. Warren, J. Biol. Chem.234, 1971 (1959).Google Scholar
  31. [31]
    R. O'Kennedy, Jr. J. Med. Sci.101, 92 (1980).Google Scholar
  32. [32]
    T. Ikenaka, M. Ishiguro, J. Emura, H. Kaufmann, S. Isemura, W. Bauer, K. Schmid, Biochemistry11, 3817 (1972).CrossRefGoogle Scholar
  33. [33]
    Sigma Technical Bulletin, MWM-100 (9–90).Google Scholar
  34. [34]
    M. Ploug, A. Jensen, V. Barknolt, Anal. Biochem.181, 33 (1989).CrossRefGoogle Scholar
  35. [35]
    Y. Burstein, K. A. Walsh, H. Neurath, Biochemistry13, 205 (1974).CrossRefGoogle Scholar
  36. [36]
    W. B. Melchior Jr., D. Fahrney, Biochemistry9, 251 (1970).CrossRefGoogle Scholar
  37. [37]
    J. Porath, B. Olin, Biochemistry22, 1621 (1983).CrossRefGoogle Scholar
  38. [38]
    O. Rossetto, G. Schiavo, P. Poverino De Laureto, S. Fabbiani, C. Montecucco, Biochem. J.285, 9 (1992).Google Scholar
  39. [39]
    M.-C. Millöt, F. Hervé, B. Sebille, J. Chromatogra. B664, 55 (1995).Google Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1997

Authors and Affiliations

  • H. Sun
    • 1
  • J. L. Dage
    • 2
  • H. B. Halsall
    • 3
  1. 1.Department of Analytical Research and DevelopmentHoffmann-La Roche, Inc.NutleyUSA
  2. 2.Hoechst Marion Roussel, Inc.CincinnatiUSA
  3. 3.Department of ChemistryUniversity of CincinnatiCincinnatiUSA

Personalised recommendations